SBIR-STTR Award

Early Detection Of Evaporative Dry Eye Syndrome (Ede)
Award last edited on: 9/20/13

Sponsored Program
SBIR
Awarding Agency
NIH : NEI
Total Award Amount
$139,220
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Bruce Chase

Company Information

PAIR Technologies LLC

1 Innovation Way Suite 304
Newark, DE 19711
   (302) 368-7247
   danfrost@pairtech.com
   www.pairtech.com
Location: Single
Congr. District: 00
County: 

Phase I

Contract Number: 1R43EY023119-01
Start Date: 1/1/13    Completed: 6/30/13
Phase I year
2013
Phase I Amount
$139,220
Dry eye (DE) affects 25-30 million people in the U.S. alone and is responsible for $3.84 billion in direct annual health care costs. Evaporative dry eye (EDE) results from a lipid deficiency in tears causing the premature evaporation of tears. The problem to be solved is that current methods for accurately diagnosing EDE take time and are expensive. A fast, objective, analytical method that can be administered during a routine eye examination (10 minutes) is needed. We propose to address this need using a ultra-fast infrared spectrograph to measure the ratio of lipid to protein in tear fluid sampled with a conventional Schirmer strip; a test routinely administered during an eye exam. The chemical constituents deposited on the Schirmer strip will be measured using a unique measurement approach, which couples separation of the chemical components along the strip and measurement of the distribution of these components with a new, multichannel measurement system employing an attenuated total reflection accessory. The primary cause of EDE is rapid tear evaporation due to low lipid levels. The onset of dry eye conditions can be pre-anticipated by changes in the lipid content of tears (a decrease in lipid to protein ratio (L/P)) measured by an infrared analysis of a tear film obtained on a Schirmer test strip. The long term goal is to provide an instrument compatible with a doctor's office that can rapidly and reliably measure the lipid to protein ratio n tears. This Phase I program will determine the L/P in synthetic and natural tears sampled with a Schirmer strip in less than two minutes with sensitivity (precision) of 1%. The Phase II program will design and construct a bench-top instrument, suitable for use in an ophthalmologist's office. It will use a standard Schirmer strip containing tears extracted from a patient during a routine ophthalmic exam and provide a measure of the lipid to protein ratio. There are more than 18,000 practicing ophthalmologists in the U.S. today. This "user-friendly", technician-operated, PA-IR instrument will allow them to track the L/P ratio for patients and provide for early detectio of the onset of evaporative dry eye (EDE).

Public Health Relevance Statement:


Public Health Relevance:
The proposed research on the analysis of tears in the course of a routine eye examination will allow the identification of tear components which can be used as a pre-diagnosis of evaporative dry eye disease. This condition, which affects 25-30 million people in the U.S. alone, is responsible for $3.84 billion in direct annual health care costs and an additional $54 billion in indirect costs and lost productivity. This will improve quality of lif, and from an economic point of view, healthcare costs for the public will be reduced.

Project Terms:
absorption; Address; Affect; Age; analytical method; Attenuated; base; Biological Assay; Chemicals; Clinical; commercial application; Cornea; Corneal Ulcer; Couples; Deposition; design and construction; Detection; Diagnosis; Drops; Dry Eye Syndromes; Duct (organ) structure; Dyes; Early Diagnosis; Economics; Elements; Environment; evaporation; Eye; Eye diseases; eye dryness; Facilities and Administrative Costs; Film; Gland; Goals; Health Care Costs; Healthcare; Heating; improved; innovation; instrument; instrumentation; Laboratories; Lipids; Liquid substance; Long-Term Effects; Measurement; Measures; Methods; migration; miniaturize; ocular surface; Office Visits; Ophthalmic examination and evaluation; Ophthalmologist; Optometrist; Osmolar Concentration; Patients; Pharmaceutical Preparations; Phase; point of care; premature; Productivity; programs; Proteins; public health relevance; rapid diagnosis; Research; Sampling; Small Business Innovation Research Grant; Sodium Chloride; Staining method; Stains; Surface; System; Techniques; technological innovation; Technology; Testing; Time; user-friendly; Vision

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----